- 3+ members traded it the same way within 14 days▲
- Larger than this member's usual trade▲
- Trade size▲
Loading the dossier
The Hill Wire · Member dossier
Kelly Morrison
DemocratRepresentative · MN-3
Ranking Member, Small Business subcommittee on Rural Development, Energy, and Supply ChainsCurrent term began Jan 2025
6.9 points ahead of the S&P 500
Copying Morrison's 10 purchases from the day each became public: +47.0%. The S&P over the same days: +40.1%.
Buys only, each purchase counted equally, not what Morrison earned. 18 of the 48 members with five or more priced purchases are ahead of the index. The typical member trails it by 2.8 points.
- Disclosed trades
- 75
- 11 purchases · 59 sales · made public since January 2025
- Disclosed volume
- $1.2M
- midpoints of the reported ranges, not what Morrison owns
- Made public
- 21 days
- Half of Morrison's trades were made public within 21 days; Congress overall 28; the law allows 45.
- On time
- 100%
- 79% across Congress
A physician serving as the U.S. representative for Minnesota's 3rd congressional district
Kelly Morrison is a physician and politician whose state legislative service included representing the western Twin Cities metropolitan area. She served in the Minnesota House of Representatives from 2019 to 2023 and the Minnesota Senate from 2023 to 2024. She has represented Minnesota's 3rd congressional district in the U.S. House since 2025.
Morrison's professional background as a physician provides context in health care. Her committee assignments include Veterans' Affairs and its Health subcommittee, along with Small Business.
physician · former state legislator
Generated with AI, awaiting an editor · from Wikipedia · not from the filings
What the filings show
Kelly Morrison, a Minnesota House Democrat, reports frequent trading dominated by sales
Sales dominate Morrison's frequent disclosures, with purchases playing a smaller role. Trading is spread across several companies but retains meaningful concentrations in leading names, including Target and Accenture. Company shares predominate, funds play a small role, and no options are reported; accounts are mostly in her own name, with some spouse activity.
What to watch
- A sustained rise in purchases would change the picture of a disclosure record dominated by sales.
- Target and Accenture are prominent names to track for shifts in where trading is concentrated.
- Most activity is filed in Morrison's own name; spouse transactions deserve separate attention when reading the record.
Generated with AI, awaiting an editor, from the member’s own filings · carries no figures and makes no claim about performance
Filings that stood out
this member's highest Signal Scores · of 100, how much a filing stands out, not a rating · sorted by score, never by price move
Public information from STOCK Act filings. Amounts are reported in ranges and shown as midpoints, filings arrive after the trades, and no personal profit or loss is disclosed. Not financial advice.